Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Schultz kept Teva away from the abyss, but couldn't find a runway to growth | Ctech
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters")
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva CEO Erez Vigodman Steps Down | CHEManager
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO steps down, replacement found — MedWatch
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva CEO Schultz likely won't renew employment contract: reports
Teva taps former Biogen exec Richard Francis as CEO - News
Richard Francis - President and Chief Executive Officer - Teva Pharmaceuticals | LinkedIn
Drug maker Teva to fire 350 workers in efficiency bid for southern Israeli plant | The Times of Israel
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva CEO Sounds Off
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Announces Appointment of Richard Francis as President and CEO | Business Wire
Teva neck-deep in legal trouble with no end in sight | Ctech
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
